I know your focus of twisting peoples comments is
Post# of 72440
Funding! This is a cost to the company that is currently diluting at sub $0.50. Adding cost to the company that has very limited funds is not what I think as a shareholder should be priority. If they have this deal written ready to once they have a partner or other backing, yes I totally agree it is important.
I still haven't sold any of my shares, which apparently I am one of very very few... But that doesn't mean I don't have an opinion that disagrees with the steps they are taking. By the way what happend to our other big developer of Brilacidin, maybe if there was an issue there it should have been discussed also. Maybe Reddy's can't produce the sachets, then explain that.
I for one am hoping that the company is sending investors signals that things are about to ramp up, but this isn't the first time that people started pumping on ideas. I just want to see the business side of the company start catching up to the trial side!
GLTM